Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Read More

Overview

Feature Articles

Latest Prostate Cancer News and Research

Genomic test may help identify prostate cancer patients at high risk of disease progression

Genomic test may help identify prostate cancer patients at high risk of disease progression

New radiotracer opens the door for advancement of iron-targeted cancer therapies

New radiotracer opens the door for advancement of iron-targeted cancer therapies

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

A low-cost biopolymer dressing to help heal chronic wounds

A low-cost biopolymer dressing to help heal chronic wounds

MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

Research reveals recovery of cancer screening tests and associated disparities after first pandemic peak

Research reveals recovery of cancer screening tests and associated disparities after first pandemic peak

Anti-androgen therapy for patients with advanced prostate cancer may fuel bone metastasis

Anti-androgen therapy for patients with advanced prostate cancer may fuel bone metastasis

Artificial intelligence program analyzes CT scans for tell-tale signs of prostate cancer

Artificial intelligence program analyzes CT scans for tell-tale signs of prostate cancer

Multimodality therapy critical for treating more aggressive prostate cancers

Multimodality therapy critical for treating more aggressive prostate cancers

Black male veterans more likely to receive radiation or surgery for prostate cancer than non-Black men

Black male veterans more likely to receive radiation or surgery for prostate cancer than non-Black men

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Study: A subset of patients with localized prostate cancer may benefit from immunotherapies

Study: A subset of patients with localized prostate cancer may benefit from immunotherapies

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Flinders University joins research alliance to tackle the challenges in men’s health

Flinders University joins research alliance to tackle the challenges in men’s health

Study uncovers new mechanisms underlying lineage plasticity

Study uncovers new mechanisms underlying lineage plasticity

Study: Cancer cells grown in culture dishes have less parity with their human sources

Study: Cancer cells grown in culture dishes have less parity with their human sources

Endocrine Society praises U.S. Supreme Court's decision to uphold the ACA

Endocrine Society praises U.S. Supreme Court's decision to uphold the ACA

Novel drug class shows potential to treat cancer patients with faulty BRCA genes

Novel drug class shows potential to treat cancer patients with faulty BRCA genes

LIM domain only 1 gene contributes to the tumorigenesis of multiple cancers

LIM domain only 1 gene contributes to the tumorigenesis of multiple cancers